Advertisement

Chirurgische Therapieoptionen bei peritonealer Metastasierung

  • B. Rau
  • E. Pachmayr
  • A. Brandl
  • W. Raue
Chapter

Zusammenfassung

Mit annähernd 1 Mio. Neuerkrankungen pro Jahr ist das Magenkarzinom weltweit die 5-häufigste Krebserkrankung. Von erheblicher Bedeutung ist dabei die geografische Region: Mehr als zwei Drittel der Patienten stammen aus sog. Entwicklungs- und Schwellenländern. Korea, Japan und die Mongolei verzeichnen die höchsten Inzidenzraten (Stewart u. Wild 2014). In Europa lässt sich ein Ost-West-Gefälle der Häufigkeit feststellen, das sich auch innerhalb Deutschlands bemerkbar macht. Seit mehreren Jahrzehnten wird hierzulande – genauso in anderen westlichen Industriestaaten – ein ständiger Rückgang von Inzidenz und Mortalität beobachtet: Das Robert-Koch-Institut registriert zwischen 1990 und 2004 einen Rückgang der altersstandardisierten Inzidenz bei Frauen um 38 % und bei Männern um 30 % (RKI 2016).

Literatur

  1. Bang YJ, Van Cutsem E, Feyereislova A et al. (2010) (2004) Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376 (9742): 687−697CrossRefPubMedGoogle Scholar
  2. Coccolini F, Cotte E, Glehen O et al. (2014) Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials. Eur J Surg Oncol 40(1): 12−26CrossRefPubMedGoogle Scholar
  3. de Bree E, Koops W, Kröger R et al. (2004) Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86(2): 64−73CrossRefPubMedGoogle Scholar
  4. Dewey WC (1984) Interaction of heat with radiation and chemotherapy. Cancer Res 44: 4714−4720Google Scholar
  5. Dromain C, Leboulleux S, Auperin A et al. (2008) Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. Abdom Imaging 33(1): 87−93CrossRefPubMedGoogle Scholar
  6. Esaki Y, Hirayama R, Hirokawa K (1990) A comparison of patterns of metastasis in gastric cancer by histologic type and age. Cancer 65(9): 2086−2090CrossRefPubMedGoogle Scholar
  7. Esquivel J, Chua TC, Stojadinovic A et al. (2010) Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol 102(6): 565−570CrossRefPubMedGoogle Scholar
  8. Facchiano E, Risio D, Kianmanesh R, Msika S (2012) Laparoscopic hyperthermic intraperitoneal chemotherapy: indications, aims, and results: a systematic review of the literature. Ann Surg Oncol 19(9): 2946−2950CrossRefPubMedGoogle Scholar
  9. Fujimoto S, Shrestha RD, Kokubun M et al. (1988) Intraperitoneal Hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 208: 36−41CrossRefPubMedPubMedCentralGoogle Scholar
  10. Garofalo A, Valle M (2009) Laparoscopy in the management of peritoneal carcinomatosis. Cancer J 15(3): 190−195CrossRefPubMedGoogle Scholar
  11. Gill RS, Al-Adra DP, Nagendran J et al. (2011) Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity. J Surg Oncol 104(6): 692−698CrossRefPubMedGoogle Scholar
  12. Glehen O, Gilly FN, Arvieux C et al. (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17(9): 2370−2377CrossRefPubMedGoogle Scholar
  13. Glehen O, Passot G, Villeneuve L et al. (2014) GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer 14:183. doi:  10.1186/1471-2407-14-183 CrossRefPubMedPubMedCentralGoogle Scholar
  14. Gretschel S, Siegel R, Estevez-Schwarz L et al. (2006) Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis. Br J Surg 93(12): 1530−1535CrossRefPubMedGoogle Scholar
  15. Hall EJ, Brenner DJ (1993) The radiobiology of radiosurgery: rationale for different treatment regimes for AVMs and malignancies [see comments]. Int J Radiat Oncol Biol Phys 25 381−385CrossRefPubMedGoogle Scholar
  16. Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH (1993) Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72(5): 1631−1636CrossRefPubMedGoogle Scholar
  17. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82: 359−374CrossRefPubMedGoogle Scholar
  18. Jeong O, Park YK, Choi WY, Ryu SY (2014) Prognostic significance of non-curative gastrectomy for incurable gastric carcinoma. Ann Surg Oncol 21(8): 2587−2593CrossRefPubMedGoogle Scholar
  19. Kang LY, Mok KT, Liu SI et al. (2013) Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion. J Chin Med Assoc 76(8): 425−431CrossRefPubMedGoogle Scholar
  20. Kim KW, Chow O, Parikh K et al. (2014) Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy. Am J Surg 207(1): 78−83CrossRefPubMedGoogle Scholar
  21. Klumpp B, Schwenzer NF, Gatidis S et al. (2014) Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT. Rofo 186(4): 359−366CrossRefPubMedGoogle Scholar
  22. Kong X, Wang JL, Chen HM, Fang JY (2012) Comparison of the clinicopathological characteristics of young and elderly patients with gastric carcinoma: a meta analysis. J Surg Oncol 106(3): 346−352CrossRefPubMedGoogle Scholar
  23. Kuramoto M, Shimada S, Ikeshima S et al. (2009) Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg 250(2): 242−246CrossRefPubMedGoogle Scholar
  24. Leake PA, Cardoso R, Seevaratnam R et al. (2012) A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer. Gastric Cancer 15 (Suppl 1): S27−37CrossRefGoogle Scholar
  25. Levy MJ, Abu Dayyeh BK, Fujii LL et al. (2015) Detection of peritoneal carcinomatosis by EUS fine-needle aspiration: impact on staging and resectability (with videos). Gastrointest Endosc 81(5): 1215−1224CrossRefPubMedGoogle Scholar
  26. Liu X, Cai H, Sheng W, Wang Y (2012) Long-term results and prognostic factors of gastric cancer patients with microscopic peritoneal carcinomatosis. PLoS One 7(5): e37284CrossRefPubMedPubMedCentralGoogle Scholar
  27. Low RN, Barone RM, Lee MJ (2013) Surveillance MR imaging is superior to serum tumor markers for detecting early tumor recurrence in patients with appendiceal cancer treated with surgical cytoreduction and HIPEC. Ann Surg Oncol 20(4): 1074−1081CrossRefPubMedGoogle Scholar
  28. Mocellin S, Nitti D (2015) Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials. Cancer Treat.Rev. 41(5): 448–454CrossRefPubMedGoogle Scholar
  29. Moehler M, Baltin CT, Ebert M et al. (2015) International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. Gastric Cancer 18(3): 550−563CrossRefPubMedGoogle Scholar
  30. Nunez MF, Sardi A, Jimenez W et al. (2015) Port-site metastases is an independent prognostic factor in patients with peritoneal carcinomatosis. Ann Surg Oncol 22(4): 1267−1273CrossRefPubMedGoogle Scholar
  31. Oba K, Paoletti X, Alberts S et al. (2013) Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. J Natl Cancer Inst 105(21): 1600−1607CrossRefPubMedPubMedCentralGoogle Scholar
  32. Okano K, Maeba T, Ishimura K et al. (2002) Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 235(1): 86−91CrossRefPubMedPubMedCentralGoogle Scholar
  33. RKI (2016) Robert-Koch-Institut. Verbreitung von Krebserkrankungen in Deutschland. RKI, pp 1−181Google Scholar
  34. Seyfried F, von Rahden BH, Miras AD et al. (2015) Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin − a longitudinal experience from a prospectively collected database of 1108 patients. BMC Cancer 15:73. doi:  10.1186/s12885-015-1081-8 CrossRefPubMedPubMedCentralGoogle Scholar
  35. Soussan M, Des GG, Barrau V et al. (2012) Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy. Eur Radiol 22(7): 1479−1487CrossRefPubMedGoogle Scholar
  36. Spratt JS, Adcock RA, Sherrill W, Travathen S (1980) Hyperthermic peritoneal perfusion system in canines. Cancer Res 40(2): 253−255PubMedGoogle Scholar
  37. Stewart BW, Wild CP (2014) International Agency for Research on Cancer. In: Stewart BW, Wild CP (eds) World cancer report 2014. IARC Nonserial PublicationGoogle Scholar
  38. Sugarbaker PH (1998) Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 14(3): 254−261CrossRefPubMedGoogle Scholar
  39. Sugarbaker PH, Jablonski KA (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221(2): 124−132CrossRefPubMedPubMedCentralGoogle Scholar
  40. Sugarbaker PH, Cunliffe WJ, Belliveau J et al. (1989) Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 16 83−97PubMedGoogle Scholar
  41. Sun J, Song Y, Wang Z et al. (2013) Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis. BMC Cancer 13:577. doi:  10.1186/1471-2407-13-577 CrossRefPubMedPubMedCentralGoogle Scholar
  42. Valle SJ, Alzahrani NA, Alzahrani SE et al. (2015) Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for refractory malignant ascites in patients unsuitable for cytoreductive surgery. Int J Surg 23 (Pt A): 176−180CrossRefPubMedGoogle Scholar
  43. Yan TD, Black D, Sugarbaker PH et al. (2007) A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 14(10): 2702−2713CrossRefPubMedGoogle Scholar
  44. Yan TD, Morris DL, Shigeki K et al. (2008) Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: Expert consensus statement. J Surg Oncol 98(4): 224−227CrossRefPubMedGoogle Scholar
  45. Yan TD, Cao CQ, Munkholm-Larsen S (2010) A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy. World J Gastrointest Oncol 2(2): 109−116CrossRefPubMedPubMedCentralGoogle Scholar
  46. Yarema RR, Ohorchak MA, Zubarev GP et al. (2014) Hyperthermic intraperitoneal chemoperfusion in combined treatment of locally advanced and disseminated gastric cancer: results of a single-centre retrospective study. Int J Hyperthermia 30(3): 159−165CrossRefPubMedGoogle Scholar
  47. Yonemura Y, Elnemr A, Endou Y et al. (2012) Effects of neoadjuvant intraperitoneal/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer. Int J Surg Oncol doi:  10.1155/2012/148420

Copyright information

© Springer-Verlag GmbH Deutschland 2017

Authors and Affiliations

  • B. Rau
    • 1
  • E. Pachmayr
    • 2
  • A. Brandl
    • 3
  • W. Raue
    • 4
  1. 1.Chirurgische Klinik m.S. Spezielle Chirurgische OnkologieUniversitätsmedizin BerlinCharité Campus MitteBerlinDeutschland
  2. 2.Chirurgische KlinikUniversitätsmedizin BerlinCharité Campus MitteBerlinDeutschland
  3. 3.Chirurgische KlinikUniversitätsmedizin BerlinCharité Campus MitteBerlinDeutschland
  4. 4.Chirurgische KlinikUniversitätsmedizin BerlinCharité Campus MitteBerlinDeutschland

Personalised recommendations